Kreon

Pancreas Powder, the active ingredient in Kreon, is a digestive enzyme presented as a powder for oral use. It supplies a mixture of lipase, protease, and amylase to support the breakdown of fats, proteins, and carbohydrates in individuals with pancreatic exocrine insufficiency.

GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with distribution originating from the European Union market and a commitment to quality and reliable logistics.

Kreon is used in the management of pancreatic exocrine insufficiency, a condition characterized by inadequate production of digestive enzymes.

- Pancreatic exocrine insufficiency: Improves digestion and nutrient absorption. - Cystic fibrosis‑related pancreatic insufficiency: Enhances fat absorption and reduces steatorrhea. - Chronic pancreatitis: Reduces malabsorption and oily stools.

Kreon may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Abdominal discomfort or cramping. - Flatulence or bloating. - Oily or fatty stools (steatorrhea). - Nausea or mild vomiting. - Constipation. - Mild dyspepsia.

Serious or Rare Side Effects: - Allergic reactions, including rash, urticaria, or anaphylaxis. - Severe abdominal pain or pancreatitis exacerbation. - Intestinal obstruction or ileus. - Hypersensitivity with respiratory distress. - Fecal incontinence. - Unexplained weight loss.

Before initiating therapy with Kreon, consider the following precautions.

- Dose adjustment: Individualize the dose based on clinical response and the fat content of meals. - Medical supervision: Use under physician guidance, especially in patients with diabetes or malnutrition. - Allergy: Avoid if the patient has a known hypersensitivity to porcine‑derived enzymes. - Interaction with antacids: Separate administration from antacids containing aluminum or magnesium to maintain efficacy. - Monitoring: Observe for signs of malabsorption, allergic reaction, or worsening pancreatitis. - Store at room temperature below 25°C: Keep in the original container, protect from moisture and direct sunlight.

Kreon can interact with several medicines; awareness of the interaction level helps guide safe use.

Major Interactions (Avoid): - Proton pump inhibitors: May reduce enzyme activity if not timed correctly. - Antacids containing aluminum or magnesium: Can bind enzymes and diminish their effect. - Orlistat: Inhibits lipase activity, markedly reducing therapeutic benefit. - Cholestyramine or other bile‑acid sequestrants: May bind enzymes and lower absorption.

Moderate Interactions (Monitor Closely): - Antibiotics that alter gut flora: May affect enzyme activity and gastrointestinal tolerance. - Diabetes medications: Changes in carbohydrate digestion can influence glucose control; monitor blood sugar. - Warfarin: Rare reports of altered INR; monitor coagulation parameters when initiating or adjusting therapy.